Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects

1. Marchio P, Guerra-Ojeda S, Vila JM, et al. Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2019; Article ID: 8563845.10.1155/2019/8563845663648231354915 Search in Google Scholar

2. Steven S, Frenis K, Oelze M, et al. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease. Oxid Med Cell Longev. 2019; 2019: 7092151.10.1155/2019/7092151661239931341533 Search in Google Scholar

3. Leiva Е, Wehinger S, Guzmán L, et al. Role of Oxidized LDL in Atherosclerosis. Hypercholesterolemia. 2015 September; Sekar Ashok Kumar, IntechOpen. Available from: https://www.intechopen.com/books/hypercholesterolemia/role-of-oxidized-ldl-in-atherosclerosis.10.5772/59375 Search in Google Scholar

4. Trpkovic A, Resanovic I, Stanimirovic J, et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular disease. Crit Rev Clin Lab Sci. 2015; 52(2): 70–85.10.3109/10408363.2014.99206325537066 Search in Google Scholar

5. Yusoff WNW, Bakar NAA, Muid S, et al. Anti-oxidant activity of HDL using different in vitro assays. Journal of fundamental and applied sciences. 2017; 9(6S): 298–315.10.4314/jfas.v9i6s.24 Search in Google Scholar

6. Ali KM, Wonnerth A, Huber K, et al. Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities. Br J Pharmacol. 2012; 167(6): 1177–1194.10.1111/j.1476-5381.2012.02081.x350498622725625 Search in Google Scholar

7. Gao S, Liu J. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chronic Dis Transl Med. 2017; 3(2): 89–94.10.1016/j.cdtm.2017.02.008562769829063061 Search in Google Scholar

8. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955; 34(9): 1345–53.10.1172/JCI10318243870513252080 Search in Google Scholar

9. de Juan-Franco E, Perez A, Ribas V, et al. Standardization of a method to evaluate the antioxidant capacity of high-density lipoproteins. Int J Biomed Sci. 2009; 5(4): 402–10. Search in Google Scholar

10. Esterbauer H, Striegl G, Puhl H, et al. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989; 6(1): 67–75.10.3109/107157689090734292722022 Search in Google Scholar

11. Alfaddagh A, Martin SS, Leucker TM, et al. Inflammation and cardiovascular disease: From mechanisms to therapeutics. American Journal of Preventive Cardiology. 2020; 4: 100130.10.1016/j.ajpc.2020.100130831562834327481 Search in Google Scholar

12. Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018; 6(9): 691–698.10.1016/S2213-2600(18)30177-2 Search in Google Scholar

13. Karmaus PWF, Shi M, Perl S, et al. Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol. JCI Insight. 2019; 4(21): e131530.10.1172/jci.insight.131530694877331573980 Search in Google Scholar

14. Ivanova EA, Myasoedova VA, Melnichenko AA, et al. Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxid Med Cell Longev. 2017; 2017: 1273042.10.1155/2017/1273042544112628572872 Search in Google Scholar

15. Nezami N, Argani H, Safa J, et al. Lovastatin enhances paraoxonase anzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy. Clinical Biochemistry. 2011; 44(2): 165–170.10.1016/j.clinbiochem.2010.10.00620970413 Search in Google Scholar

16. Thallinger C, Urbauer E, Lackner E, et al. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients. Int J Clin Pharmacol Ther. 2005; 43(12): 551–7.10.5414/CPP43551 Search in Google Scholar

17. Portal VL, Moriguchi EH, Vieria JL, et al. Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation. Arquivos Brasileiros de Cardiologia. 2003; 80(2): 156–161.10.1590/S0066-782X2003000200004 Search in Google Scholar

18. Pirillo A, Catapano AL. Pitavastatin and HDL: Effects on plasma levels and function(s). Atheroscler Suppl. 2017; 27:e1-e9.10.1016/j.atherosclerosissup.2017.05.00128716185 Search in Google Scholar

19. Triolo M, Annema W, de Boer JF, et al. Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. Eur J Clin Invest. 2014; 44(3): 240–8.10.1111/eci.1222624325778 Search in Google Scholar

20. Parthasarathy S, Raghavamenon A, Garelnabi MO, et al. Oxidized low-density lipoprotein. Methods Mol Biol. 2010; 610: 403–417.10.1007/978-1-60327-029-8_24331535120013192 Search in Google Scholar

21. Fessler MB, Rose K, Zhang Y, et al. Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population. J Lipid Res. 2013; 54(11): 3177–3188.10.1194/jlr.P037614379362223999863 Search in Google Scholar

22. Wang X, Yang L, Liu Y, et al. Oxidized low-density lipoprotein (Ox-LDL) impacts on erythrocyte viscoelasticity and its molecular mechanism. Journal of Biomechanics. 2009; 42(14): 2394–2399.10.1016/j.jbiomech.2009.05.02619747680 Search in Google Scholar

23. Rhoads JP, Major AS. How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses. Crit Rev Immunol. 2018; 38(4): 333–342.10.1615/CritRevImmunol.2018026483652711030806246 Search in Google Scholar

24. Pirillo A, Norata GD, Catapano AL. LOX-1, Ox-LDL and Atherosclerosis. Mediators of Inflammation. 2013; 152786.10.1155/2013/152786372331823935243 Search in Google Scholar

25. McCarthy DA, Ranganathan A, Subbaram S, et al. Redox-control of the alarmin, Interleukin-1α. Redox Biol. 2013; 1(1): 218–225.10.1016/j.redox.2013.03.001375769324024155 Search in Google Scholar

26. Liu T, Zhang L, Joo D, et al. NF-kB signaling in inflammation. Signal Transduction and Targeted Therapy. 2017; 2: 17023.10.1038/sigtrans.2017.23566163329158945 Search in Google Scholar

27. Tao J, Zhang D, Zhang D, et al. Effect of sodium ferulate on IL-8 expression induced by Ox-LDL in human umbilical vein endothelial cells. Biomedical Research. 2017; 28(5). Search in Google Scholar